Imperagen Secures £5 Million for Quantum AI Innovations
May 21, 2026 at 04:00
0
✦ AI Summary
- Imperagen raises £5 million in seed funding
- Funding will focus on enzyme engineering breakthroughs
- Investors include PXN Ventures, IQ Capital, and Northern Gritstone
Biotech startup Imperagen has successfully secured £5 million (approximately $6.7 million) in seed funding, aiming to leverage quantum physics and AI for innovative enzyme engineering. This funding round, led by PXN Ventures, saw participation from notable investors including IQ Capital and Northern Gritstone.
The investment will enable Imperagen to accelerate its research and development efforts, positioning itself at the forefront of biotechnology innovation through the application of advanced technologies.
Share: